NCT07899710Not yet recruiting
Neurological Rehabilitation and Neuroplasticity After Ischemic Stroke
Effects of Neurological Rehabilitation on the Expression of Neuroplasticity Markers and Neurotransmitter Profiles in Patients at Different Stages Following Ischemic Stroke
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This observational study evaluates the effects of neurological rehabilitation on biological markers associated with neuroplasticity and neurotransmitter profiles in patients after ischemic stroke. The study will include patients at different stages after stroke who undergo neurological rehabilitation as part of their standard care. The aim of the study is to assess whether rehabilitation is associated with changes in neuroplasticity-related markers and neurotransmitter levels, which may contribute to a better understanding of recovery processes after ischemic stroke.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 20 Oct 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2028
- Lead sponsor
- Medical University of Lodz
- Diseases
- Stroke
- NCT number
- NCT07899710
What you commit to
- Study type: Observational
- Planned participants: 60
- From Oct 2026 to the primary completion date, Oct 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe cardiovascular diseases, including myocardial infarction within the previous 30 days, unstable angina, or heart failure.
Other illness
- Hemorrhagic stroke.
- Severe general condition.
- Presence of brain tumors or other diseases of the central nervous system.
- Inflammatory diseases accompanied by fever.
- Systemic diseases.
- Severe arrhythmia.
- Uncontrolled metabolic and endocrine diseases.
- Respiratory failure.
Other
- Lack of patient consent to participate in the study.
Who the study is looking for
- Age \>18 years.
- Diagnosis of ischemic stroke according to ICD-10 code I63.
- Subacute phase of ischemic stroke (7 days to 6 months after stroke onset).
- Written informed consent provided by the patient for participation in the study.
- Ability to establish basic logical verbal communication.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.